These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 13767183)

  • 1. Streptonigrin, an antitumor agent produced by strains of Streptomyces flocculus. I. Microbiological studies.
    MARSH WS; GARRETSON AL; WESEL EM
    Antibiot Chemother (Northfield); 1961 Mar; 11():151-7. PubMed ID: 13767183
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel streptonigrin type alkaloid from the
    Wang X; Xu F; Huang T; Deng Z; Lin S
    Nat Prod Res; 2022 Jul; 36(13):3337-3345. PubMed ID: 33280413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tryptophan C-methyltransferase involved in streptonigrin biosynthesis in Streptomyces flocculus.
    Hartley DL; Speedie MK
    Biochem J; 1984 May; 220(1):309-13. PubMed ID: 6743267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of S-adenosylhomocysteine deaminase from streptonigrin-producing Streptomyces flocculus.
    Zulty JJ; Speedie MK
    J Bacteriol; 1989 Dec; 171(12):6840-4. PubMed ID: 2592350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of a metabolic grid at an early step in the streptonigrin biosynthetic pathway in Streptomyces flocculus.
    Speedie MK; Hartley DL
    J Antibiot (Tokyo); 1984 Feb; 37(2):159-66. PubMed ID: 6706852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry, Biosynthesis and Pharmacology of Streptonigrin: An Old Molecule with Future Prospects for New Drug Design, Development and Therapy.
    Nabihah Nasir N; Sekar M; Ravi S; Wong LS; Sisinthy SP; Gan SH; Subramaniyan V; Chidambaram K; Mat Rani NNI; Begum MY; Ramar M; Safi SZ; Selvaraj S; Chinna Maruthu SK; Fuloria S; Fuloria NK; Lum PT; Djearamane S
    Drug Des Devel Ther; 2023; 17():1065-1078. PubMed ID: 37064433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of (2S,3S)-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin.
    Kong D; Zou Y; Zhang Z; Xu F; Brock NL; Zhang L; Deng Z; Lin S
    Sci Rep; 2016 Feb; 6():20273. PubMed ID: 26847951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary observations on the use of streptonigrin as an antitumor agent in human beings.
    WILSON WL; LABRA C; BARRIST E
    Antibiot Chemother (Northfield); 1961 Mar; 11():147-50. PubMed ID: 13785724
    [No Abstract]   [Full Text] [Related]  

  • 9. Xantholipin B produced by the stnR inactivation mutant Streptomyces flocculus CGMCC 4.1223 WJN-1.
    Wu S; Huang T; Xie D; Wo J; Wang X; Deng Z; Lin S
    J Antibiot (Tokyo); 2017 Jan; 70(1):90-95. PubMed ID: 27328868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of streptonigrin biosynthesis reveals a cryptic carboxyl methylation and an unusual oxidative cleavage of a N-C bond.
    Xu F; Kong D; He X; Zhang Z; Han M; Xie X; Wang P; Cheng H; Tao M; Zhang L; Deng Z; Lin S
    J Am Chem Soc; 2013 Feb; 135(5):1739-48. PubMed ID: 23301954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of 4-aminoanthranilic acid: a new shikimate pathway product from Streptomyces flocculus.
    Gould SJ; Erickson WR
    J Antibiot (Tokyo); 1988 May; 41(5):688-9. PubMed ID: 3384755
    [No Abstract]   [Full Text] [Related]  

  • 12. Streptonigrin, an antitumor substance. I. Isolation and characterization.
    RAO KV; CULLEN WP
    Antibiot Annu; 1959-1960; 7():950-3. PubMed ID: 14436228
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of agitation-induced shear stress on mycelium morphology and lavendamycin production by engineered Streptomyces flocculus.
    Xia X; Lin S; Xia XX; Cong FS; Zhong JJ
    Appl Microbiol Biotechnol; 2014 May; 98(10):4399-407. PubMed ID: 24522728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinone natural products: streptonigrin (NSC-45383) and lapachol (NSC-11905) structure-activity relationships.
    Rao KV
    Cancer Chemother Rep 2; 1974 Dec; 4(4):11-7. PubMed ID: 4451909
    [No Abstract]   [Full Text] [Related]  

  • 15. [Induction of antibiotic formation by inactive cultures of actinomycetes. A mutant strain of Streptomyces helvaticus, a new producer of bruneomycin].
    Malkina ND; Dudnik IuV; Lysenkova LN; Terekhova LP; Katrukha GS
    Antibiot Khimioter; 1995 Jun; 40(6):3-6. PubMed ID: 8593091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of novel 6-substituted lavendamycin antitumor agents.
    Seradj H; Cai W; Erasga NO; Chenault DV; Knuckles KA; Ragains JR; Behforouz M
    Org Lett; 2004 Feb; 6(4):473-6. PubMed ID: 14961601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METHYL ESTER OF STREPTONIGRIN (NSC-45384) IN TREATMENT OF MALIGNANT LYMPHOMA.
    RIVERS SL; WHITTINGTON RM; MEDREK TJ
    Cancer Chemother Rep; 1965 May; 46():17-21. PubMed ID: 14327548
    [No Abstract]   [Full Text] [Related]  

  • 18. CONTINUOUS INTRAVENOUS INFUSION OF STREPTONIGRIN (NSC-45383) IN PATIENTS WITH BRONCHOGENIC CARCINOMA.
    MCCRACKEN S; ABOODY A
    Cancer Chemother Rep; 1965 May; 46():23-6. PubMed ID: 14327549
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with streptonigrin.
    HUMPHREY EW; BLANK N
    Cancer Chemother Rep; 1961 Jun; 12():99-103. PubMed ID: 13716809
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological assay of streptonigrin (NSC 45383) in body fluids and tissues of mice.
    Pittillo RF; Woolley C
    Antimicrob Agents Chemother; 1974 Jan; 5(1):82-5. PubMed ID: 4209070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.